GLP-1 Market
LLY $1150.99 ▼ -1.6% NVO $38.17 ▼ -3.1% PFE $28.18 ▲ +0.9% VKTX $41.65 ▲ +2.0% KLRA $13.13 ▲ +2.7% GPCR $35.95 ▼ -2.6% RHHBY $55.06 ▼ -0.9%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Phentermine/Topiramate ER

Company
St. Jude Children's Research Hospital
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Sep 24, 2026

Trial details
  • Completed NCT NCT01834404

    Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients

    Not yet reported Mayo Clinic 24 participants Est. completion 2014-03 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02635386

    EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)

    Not yet reported Woman's 119 participants Est. completion 2020-10-09 1 site
    Other conditions: Polycystic Ovary Syndrome, Obesity
    View official trial listing →
  • Not yet recruiting NCT NCT07728812

    Pragmatic Trial to Study the Cost-Effectiveness of MyPhenome-RX Test to Guide Anti-Obesity Pharmacotherapy

    Not yet reported Phenomix Sciences 424 participants Est. completion 2029-01-01
    Other conditions: Obesity & Overweight
    View official trial listing →
  • Not yet recruiting NCT NCT07790913

    Obesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and Lymphoma

    Not yet reported St. Jude Children's Research Hospital 100 participants Est. completion 2031-08 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia in Remission, Hodgkin Lymphoma in Remission, Non-Hodgkin Lymphoma in Remission, Cancer Survivorship
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.